4Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic[J]. Arch Intern Med,1991 15(6) :1786-1792.
5Zannad F. Aldosterone antagonist in resistant hypertension [ J ]. J Hypertens ,2007,25 ( 4 ) : 747 -750.
6Hermida RC,Ayala DE,Calvo C, et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistanthypertension [ J ]. Hypertension ,2005,46 ( 2 ) : 1053-1059.
7Wenzel U, Thaiss F, Helmchen U, et a. Angiotensin Ⅱ receptor antagonists in arterial hypertension[J]. J hum hypertens, 2000,14 (suppl1) :S69-S72.
8Neutel J M ,Bedigian M P. Efficacy of valsartan in patients aged> 65 years with systolic hypertension[J]. Clin Ther, 2000,22 (8) : 961-969.
9Chapman N, Dobson J,Wilson S, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension [ J 1. Hypertension, 2007,49 (4) : 839 -845.
10Krum H ,Nolly H ,Workman D,et al. Efficacy of eplerenone added to renin-angiotensin blockade in hyperlensive patients [ J ]. Hypertension, 2002,40 : 117- 123.
3Mancia G,De Backer G,Dominiczak A. 2007 Guidelines for the Management of Arterial Hypertension:The task force for the management of arterial hypertension of the Eurpean society of hypertension (ESH) and of the European society of cardiology (ESC)[J].{H}Journal of Hypertension,2007,(08):1105-1187.
